1-3 of 3
Jessica S. Little
Close
Sort by
Journal Articles

Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor survival

Clinical Trials & Observations
Roman M Shapiro, Haesook T Kim, Remy Dulery, Deborah Liney, Heather M Garrity, Kevin M. Panaro, Chloe Au, Casey Gervais, Jessica S. Little, Vincent T. Ho, Corey S. Cutler, John Koreth, Mahasweta Gooptu, Joseph H. Antin, Amar H. Kelkar, Rizwan Romee, Catherine J. Wu, Jerome Ritz, Robert J. Soiffer, Sarah Nikiforow
Journal: Blood Advances
Blood Adv bloodadvances.2023012418.
https://doi.org/10.1182/bloodadvances.2023012418
Published: 2024
Includes: Supplemental data
Journal Articles

Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy

Jessica S. Little, Megha Tandon, Joseph Seungpyo Hong, Omar Nadeem, Adam S. Sperling, Noopur Raje, Nikhil Munshi, Matthew Frigault, Sara Barmettler, Sarah P. Hammond
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5485–5495.
https://doi.org/10.1182/bloodadvances.2023010524
Published: 2023
Journal Articles

Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma

Jessica S. Little, Muneerah M. Aleissa, Katherine Beluch, Isabel H. Gonzalez-Bocco, Francisco M. Marty, Jennifer Manne-Goehler, Sophia Koo, Sarah P. Hammond, Caron A. Jacobson
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4821–4830.
https://doi.org/10.1182/bloodadvances.2022007474
Published: 2022